
Covaxin 77.8% effective after Phase 3 trials
Bharat Biotech’s Covaxin is overall 77.8 percent effective against Covid, the vaccine maker said on Saturday in a statement, citing the data from the third phase of clinical trials…reports Asian Lite News.